Application 214017
- Type
- ANDA
- Sponsor
- SCIEGEN PHARMS INC
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | DROXIDOPA | DROXIDOPA | CAPSULE;ORAL | 100MG | No | No |
| 002 | DROXIDOPA | DROXIDOPA | CAPSULE;ORAL | 200MG | No | No |
| 003 | DROXIDOPA | DROXIDOPA | CAPSULE;ORAL | 300MG | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 50228-429 | Droxidopa | droxidopa | ScieGen Pharmaceuticals Inc | ANDA | Current |
| 50228-430 | Droxidopa | droxidopa | ScieGen Pharmaceuticals Inc | ANDA | Current |
| 50228-431 | Droxidopa | droxidopa | ScieGen Pharmaceuticals Inc | ANDA | Current |